ArticleCell reports. Medicine2024

Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma.

Giulia Grisendi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.